Highlights
TSX: CTX       Crescita Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
0.90   0.00 (0.00%)  0.89 - 0.93  43,965

Overview

 
Avg Volume (4 weeks):0
52 Weeks Range:0.40 - 0.93
52 Weeks Price Volatility (%):
94.34%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Crescita Therapeutics Inc. is a drug development company. The Company owns products for treating medical conditions in dermatology and pain. It owns various drug delivery platforms, which include Durapeel and Foam technology to support the development of patented formulations that can deliver actives into or through the skin. It operates two business units: the Topical Products and Technology (TPT) Group and the Immunology Group. The TPT Group product, Pliaglis and other products are focused on dermatology and pain. Its product Flexicaine is in Phase II clinical stage and has therapeutic area in Tick-borne disease. Its product Ibuprofen Foam is in pre-clinical stage and has therapeutic area in Acute Pain. Its product Terbinafine is in pre-clinical stage and has therapeutic area in Onychomycosis. Its product Mical 1 is in pre-clinical stage and has therapeutic area in Psoriasis. Its product Mical 2 is in pre-clinical stage and has therapeutic area in Dermatological skin treatment.

  Be the first to like this.
 


 

1263  939  1421  978 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ACB 3.47+0.03 
 CNQ 40.08-0.04 
 ECA 5.56+0.04 
 VLE 0.48-0.56 
 BBD.B 1.920.00 
 POW 34.42+2.52 
 AQN 18.59+0.06 
 SU 41.90-0.15 
 CPG 5.060.00 
 MFC 25.40-0.25 
Partners & Brokers